Landmark Wealth Management (New York)’s Bristol-Myers Squibb BMY Stock Holding History

Landmark Wealth Management (New York)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$875K	Buy	+14,424	New	+$841K	0.23%	79
2022 Q2	–	Sell	-610	Closed	-$610	–	58
2022 Q1	$610	Buy	+610	New	+$41K	﹤0.01%	114

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Landmark Wealth Management (New York)'s BMY Position: Q1 2026 in Review

Landmark Wealth Management (New York) opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 14,424 shares worth $875K. The stake represents 0.23% of the portfolio and ranks #79 among its holdings. This is a return to the name: Landmark Wealth Management (New York) previously reported a position in BMY as recently as Q1 2022.

Landmark Wealth Management (New York) first reported a position in BMY in Q1 2022 and has held it in 2 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Landmark Wealth Management (New York) held 14,424 shares of Bristol-Myers Squibb worth $875K as of Q1 2026.
Bristol-Myers Squibb was a new Landmark Wealth Management (New York) position in Q1 2026.
Bristol-Myers Squibb made up 0.23% of Landmark Wealth Management (New York)'s portfolio in Q1 2026, its #79 holding.
Landmark Wealth Management (New York) first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 2 quarters since.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Landmark Wealth Management (New York)'s 13F filing for Q1 2026, filed 29 Apr 2026.